In this Viewpoint, Berwick and Gaines review common misconceptions about Health Insurance Portability and Accountability Act (HIPAA) requirements regarding personal health information and propose steps the Department of Health and Human Services (DHHS) can take to better balance privacy protections with the need to ensure health information is available for clinical care in reasonable time at reasonable expense.
This Viewpoint posits that HIPAA no longer fully protects health information in today’s big data era in which health data are collected and exchanged in nonclinical settings, such as social media, apps, and search engines, and proposes principles around which reform of health information privacy protections should be organized.
This Viewpoint discusses personal health information on social media and other sites and ways in which this information can and should be protected.
This narrative medicine essay explores the difference between understanding a dire prognosis and believing it.
This cluster randomized clinical trial determines whether a multifaceted quality improvement intervention can improve adherence to evidence-based performance measures in patients with acute ischemic stroke in China.
This 24-month cohort study tracks high school students in Los Angeles County, California, who were not initially assessed as having ADHD symptoms to compare frequency of use of digital media platforms with experiencing ADHD symptoms.
This population epidemiology study characterizes trends in care in the intensive care unit during the last 30 days of life and in posthospital transitions and site of death among Medicare beneficiaries who died between 2000 and 2015.
This 2018 Recommendation Statement from the US Preventive Services Task Force concludes that current evidence is insufficient to assess the balance of benefits and harms of adding ABI, hsCRP, or CAC score measures to traditional risk assessment for CVD in asymptomatic adults to prevent CVD events (I statement).
This systematic review to support the 2018 US Preventive Services Task Force Recommendation Statement on use of nontraditional risk factors in cardiovascular disease risk assessment summarizes published evidence on the benefits and harms of using ABI, hsCRP, and CAC score measures in CVD risk assessment and decisions about initiation of preventive therapy.
A 78-year-old man with a carcinoembryonic antigen (CEA) level of 11.0 ng/mL but no evidence of metastasis underwent a right hemicolectomy (surgical pathology showed a 5.5-cm adenocardinoma with 0 of 19 lymph nodes positive for cancer). At 6 months, CEA was 3.0 ng/mL. At 12 months, CEA was 5.1 ng/mL and then 6.1 ng/mL with repeat testing. What would you do next?
This study used the Drugs@FDA database to review FDA-approved “breakthrough” therapies from 2012 to 2017 (characterizing the pivotal clinical trials that serve as the basis of FDA approval), and premarket development and review times to assess the strength of evidence supporting breakthrough approvals.
In this Medical News article, frequent traveler Rachel Zang, MD, talks about her experiences helping ill patients aboard commercial airline flights and discusses what all physicians should know about in-flight medical emergencies.
This Medical News story discusses different approaches to treating normal-weight individuals who have metabolic abnormalities that are usually associated with overweight and obesity.
This JAMA Patient Page describes the US Preventive Services Task Force recommendations on assessment for cardiovascular disease using nontraditional risk factors.